$DMRA
Damora Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Waltham, MA
DMRA chart
What traders are saying about $DMRA
Latest postsDamora Therapeutics, Inc. news
- Damora Therapeutics, Inc. Estimates – NASDAQ:DMRA
TradingView ·
- Winnebago Industries Posts Upbeat Q4 Earnings, Joins SpaceX, Super Micro Computer And Other Big Stocks Mo
Benzinga ·
- Damora Therapeutics (DMRA) Stock Looks Above Fair Value On Book Value
Yahoo Finance ·
- Damora Therapeutics (DMRA) Climbed, So What Is Drawing Attention Now?
Yahoo Finance ·
- Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Damora Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Yahoo Finance ·
- Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis
Yahoo Finance ·
- Damora Announces Redomestication from Delaware to Cayman Islands
Yahoo Finance ·
- Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Yahoo Finance ·
- What Damora Therapeutics (DMRA)'s CEO Shake-Up and Finance Refresh Means For Shareholders
Yahoo Finance ·
- Damora Therapeutics (DMRA) Appoints Jennifer Jarrett as President, Chief Executive Officer
Yahoo Finance ·
- Assessing Damora Therapeutics (DMRA) Valuation After CFO Transition And Recent Share Price Momentum
Yahoo Finance ·
Damora Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$209.8M | -$21.4M | -$38.3M | -$61.6M |
| Diluted EPS | $3.98 | $-18.53 | $-36.08 | $-2.43 |
| Total assets (year end) | $260.5M | $17.1M | $38.2M | $73.2M |
| Cash and equivalents (year end) | $257.6M | $14.2M | $21.5M | $32.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Damora Therapeutics, Inc.
- Ticker
- DMRA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1800315
- Former names
- Galecto, Inc., Galecto Inc.
Frequently asked questions
What exchange is Damora Therapeutics, Inc. listed on?
Damora Therapeutics, Inc. trades on the Nasdaq under the ticker symbol DMRA.
What industry is Damora Therapeutics, Inc. in?
Damora Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Damora Therapeutics, Inc. headquartered?
Damora Therapeutics, Inc.'s business address on file with the SEC is in Waltham, MA.
When does Damora Therapeutics, Inc.'s fiscal year end?
Damora Therapeutics, Inc.'s fiscal year ends on December 31.